Financhill
Buy
51

DARE Quote, Financials, Valuation and Earnings

Last price:
$2.16
Seasonality move :
14.92%
Day range:
$2.10 - $2.18
52-week range:
$1.61 - $9.19
Dividend yield:
0%
P/E ratio:
95.38x
P/S ratio:
438.05x
P/B ratio:
10.85x
Volume:
94K
Avg. volume:
233.9K
1-year change:
-32.19%
Market cap:
$31M
Revenue:
$9.8K
EPS (TTM):
-$1.78

Earnings Data

Next earnings date for DARE
Mar 30
2026
Most recent earnings per share
-$0.28
Beat by $0.12
(Nov 13/2025)
Consensus Estimate
-$0.40
(Nov 13/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

DARE Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/30/2026 Q4 $765K -- -- -$0.43 --
11/13/2025 Q3 -- $2.3K -$0.28 -$0.40 $0.12
08/14/2025 Q2 $141.5K -$21.2K -$0.45 -$0.58 $0.13
05/13/2025 Q1 -- $25.4K -$0.50 -$0.58 $0.08
03/31/2025 Q4 $1M -- -- -$0.63 --
11/14/2024 Q3 $2M $41.7K -$0.55 -$0.71 $0.16
08/12/2024 Q2 $189.3K $22.4K $1.52 -$0.66 $2.18
05/14/2024 Q1 $260.5K $9.3K -$0.81 -$0.72 -$0.09
03/28/2024 Q4 $1.5M $1.8M -$0.61 -$0.96 $0.35
11/09/2023 Q3 $385.7K $1M -$1.09 -$1.20 $0.11
08/10/2023 Q2 -- -- -$1.22 -- --
05/11/2023 Q1 -- -- -$1.13 -- --
03/30/2023 Q4 -- -- -$2.26 -- --
11/10/2022 Q3 -- -- -$0.99 -- --
08/09/2022 Q2 -- $10M $0.06 -- --
05/12/2022 Q1 -- -- -$1.20 -- --
03/31/2022 Q4 -- -- -$1.36 -- --
11/10/2021 Q3 -- -- -$2.15 -- --
08/12/2021 Q2 -- -- -$2.18 -- --
05/13/2021 Q1 -- -- -$1.97 -- --
03/30/2021 Q4 -- -- -$2.62 -- --
11/12/2020 Q3 -- -- -$2.88 -- --
08/12/2020 Q2 -- -- -$3.20 -- --
03/31/2020 Q1 -- -- -$2.16 -- --
12/31/2019 Q4 -- -- -$2.50 -- --
09/30/2019 Q3 -- -- -$2.44 -- --
06/30/2019 Q2 -- -- -$3.53 -- --
03/31/2019 Q1 -- -- -$3.21 -- --
12/31/2018 Q4 -- -- -$3.06 -- --
09/30/2018 Q3 -- -- -$2.70 -- --
06/30/2018 Q2 -- -- -$3.76 -- --
03/31/2018 Q1 -- -- -$10.56 -- --
12/31/2017 Q4 -- -- -$18.12 -- --
09/30/2017 Q3 -- -- -$3.96 -- --
06/30/2017 Q2 -- -- -$66.00 -- --
03/31/2017 Q1 -- -- -$32.40 -- --
12/31/2016 Q4 -- $766K -$20.40 -- --
09/30/2016 Q3 -- -- -$43.20 -- --
06/30/2016 Q2 -- -- -$48.00 -- --
03/31/2016 Q1 -- -- -$58.80 -- --
12/31/2015 Q4 -- -- -$46.80 -- --

Daré Bioscience, Inc. Earnings Questions

  • How Much did Daré Bioscience, Inc. Generate in Revenue Last Quarter?

    Daré Bioscience, Inc. reported $2.3K worth of top line sales in its most recent quarter.

  • Did Daré Bioscience, Inc. Beat Earnings Last Quarter?

    Daré Bioscience, Inc. announced earnings per share of -$0.28 which represents a beat of analyst forecast a -$0.40 per share.

  • Is Daré Bioscience, Inc. Profitable?

    Daré Bioscience, Inc. reported -$610.6K that represents -$0.05 per share over the last quarter.

  • What is the Analyst Consensus for Daré Bioscience, Inc. EPS Next Year?

    Daré Bioscience, Inc.'s earnings are forecast to decrease from -$0.48 per share to -$0.46 per share next year representing a decrease of -246.96%.

  • When is Daré Bioscience, Inc.'s Earnings Date?

    Daré Bioscience, Inc.'s next earnings date is March 30, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
56
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock